Principles of antibiotic therapy in severe infections: Optimizing the therapeutic approach by use of laboratory and clinical data

被引:85
作者
Deresinski, Stan
机构
[1] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[2] Santa Clara Valley Med Ctr, Div Infect Dis, San Jose, CA 95128 USA
[3] Sequoia Hosp, Redwood City, CA USA
关键词
D O I
10.1086/519472
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The increasingly daunting problem of antimicrobial resistance has led to an intense focus on optimization of antibiotic therapy, with simultaneous goals of improving patient outcomes and minimizing the contribution of that therapy to making the available antibiotics obsolete. Although even appropriate antibiotic therapy drives resistance, inappropriate therapy may also have adverse effects on the individual patient, as well as on the bacterial ecology. Recent research has validated the benefit of intelligent utilization of both microbiological data and clinical assessment in the empirical selection of initial broad-spectrum therapy and in further guidance of therapeutic decisions throughout the course of illness by use of a systems approach. Thus, the optimal approach to the critically ill patient with infection involves the initiation of aggressive broad-spectrum empirical therapy followed by timely responses to microbiological and clinical results as they become available. An appropriate response to this information often involves de-escalation of therapy or even its discontinuation.
引用
收藏
页码:S177 / S183
页数:7
相关论文
共 32 条
[2]  
[Anonymous], CAMP PREV ANT RES HE
[3]   Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals [J].
Bergstrom, CT ;
Lo, M ;
Lipsitch, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13285-13290
[4]   Antibiotic cycling or rotation: a systematic review of the evidence of efficacy [J].
Brown, EM ;
Nathwani, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) :6-9
[5]   Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial [J].
Chastre, J ;
Wolff, M ;
Fagon, JY ;
Chevret, S ;
Thomas, F ;
Wermert, D ;
Clementi, E ;
Gonzalez, J ;
Jusserand, D ;
Asfar, P ;
Perrin, D ;
Fieux, F ;
Aubas, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19) :2588-2598
[6]   Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity [J].
Clec'h, C ;
Timsit, JF ;
De Lassence, A ;
Azoulay, E ;
Alberti, C ;
Garrouste-Orgeas, M ;
Mourvilier, B ;
Troche, G ;
Tafflet, M ;
Tuil, O ;
Cohen, Y .
INTENSIVE CARE MEDICINE, 2004, 30 (07) :1327-1333
[7]   Healthcare-associated pneumonia in adults: management principles to improve outcomes [J].
Craven, DE ;
Palladino, R ;
McQuillen, DP .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (04) :939-+
[8]   Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship [J].
Dellit, Timothy H. ;
Owens, Robert C. ;
McGowan, John E., Jr. ;
Gerding, Dale N. ;
Weinstein, Robert A. ;
Burke, John P. ;
Huskins, W. Charles ;
Paterson, David L. ;
Fishman, Neil O. ;
Carpenter, Christopher F. ;
Brennan, P. J. ;
Billeter, Marianne ;
Hooton, Thomas M. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :159-177
[9]   Counterpoint:: Vancomycin and Staphylococcus aureus -: An antibiotic enters obsolescence [J].
Deresinski, Stan .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) :1543-1548
[10]  
FOX BC, 2004, 42 ANN M INF DIS SOC, P73